ALX Oncology competitorsClear all

ALX Oncology's top competitors include DNAtriX, Eikonoklastes Therapeutics, Dendreon and Seattle Genetics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
ALX Oncology
ALX Oncology
ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment.
DNAtriX
DNAtriX
DNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer.
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a developer of tissue factor (TF) immunotherapies for triple-negative breast cancer (TNBC) and several other diseases.
Dendreon
Dendreon
Dendreon is a commercial-stage biopharmaceutical company.
Seattle Genetics
Seattle Genetics
Seattle Genetics is dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells.
Founding Date
Founding Date
2015
Founding Date
2005
Founding Date
2019
Founding Date
1992
Founding Date
1998
Type
Type
Private
Type
Private
Type
Private
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Burlingame, US HQ
Dublin 2, IE
Locations
Houston, US HQ
San Diego, US
Locations
Cincinnati, US HQ
Locations
Seal Beach, US HQ
Seattle, US
Union City, US
Locations
Bothell, US HQ
Zug, CH
Bothell, US
Employees
Employees
366% increase
Employees
254% increase
Employees
7
Employees
660
Employees
1,60523% increase
Twitter followers
Twitter followers
212
Twitter followers
206
Twitter followers
N/A
Twitter followers
2.5 k
Twitter followers
119
Number of tweets (last 30 days)
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.7
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
80%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
562840
Alexa Website Rank
N/A
Alexa Website Rank
384086
Alexa Website Rank
N/A

Funding

Latest funding round
Latest funding round
$ 105m (over 1 year ago)
Latest funding round
$ 15.5m (about 3 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 166m
Total funding raised
$ 54.2m
Total funding raised
$ 1.1m
Total funding raised
N/A
Total funding raised
$ 164m
For sources of this data, please see the company profile

View company profiles

DNAtriX
HQ
Houston, US
Employees
25↑ 4% increase

DNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer.

View company
Eikonoklastes Therapeutics
HQ
Cincinnati, US
Employees
7

Eikonoklastes Therapeutics is a developer of tissue factor (TF) immunotherapies for triple-negative breast cancer (TNBC) and several other diseases.

View company
Dendreon
HQ
Seal Beach, US

Dendreon is a commercial-stage biopharmaceutical company.

View company
Seattle Genetics
HQ
Bothell, US
Employees
1,605↑ 23% increase

Seattle Genetics is dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells.

View company